Skip to main content

Oregon State Flag An official website of the State of Oregon »

Oregon.gov Homepage

Prescription Drug Affordability Board (PDAB)

Application deadline extended - Oregon PDAB seeks applicants to fill board vacancy; apply by July 7

The Oregon Prescription Drug Affordability Board is seeking applicants to fill a vacancy. Board members must be Oregon residents with expertise in health care economics and clinical medicine. The board encourages clinicians with knowledge and experience in the lifecycle of patient care to apply. To apply, submit an application in Workday by Monday, July 7, 2025.

The board consists of eight members appointed by the governor and confirmed by the Senate. Members serve four years and can seek reappointment. The time commitment is about 10 hours per month, including virtual board meetings held on the third Wednesday of the month. The new member will begin serving in October.

The next PDAB
meeting is:

Wednesday, November 19, 2025
8 A.M. Pacific Time

Register here 

Agenda materials

Thank you for participating in the prescription drug surveys!

Prescription Drug Affordability Board Newsletter Oct. 8, 2025

The Oregon Prescription Drug Affordability Board would like to thank you for participating in the surveys about the prescription drugs under review. Survey information was included in the drug review reports. The surveys are now closed. To learn more about the PDAB drug review process, read the October 2025 newsletter or click on the newsletter cover photo. Find information in the newsletter about the newest board member, Michele Koder, and the new executive director of PDAB, Sarah Young.

The board invites your continued participation in the process. If you would like to speak during the public comment portion of a board meeting, please submit the public comment form 24 hours before the meeting. If you would like to write a letter to the board, submit the public comment form 48 hours before the meeting. Letters submitted after the 48-hour timeframe will be reviewed by the board for the following meeting. All letters are posted on the PDAB board calendar page by the month they were submitted. Letters specific to drugs under review are also posted on the PDAB drug review page.